Jenner & Block

“Biologics Litigation: The Biosimilars Wars,” ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators

Jenner & Block Partners Louis E. Fogel and Shaun M. Van Horn and Associate Susan A. O’Brien wrote a book chapter titled “Biologics Litigation: The Biosimilars Wars” that has been published in the third edition of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators (American Bar Association).   Examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and US patent law, this in-depth resource balances perspectives from both name-brand drug patentees and generic drug manufacturers. Their chapter focuses on the developing BPICA caselaw as well as practical strategies and tactics employed by the litigants, including navigating the pre-litigation “patent dance.”